BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• 

  Collaboration

  Merck Commits Nearly $2B for Oral Lipid-Lowering Drug from Chinese Biotech

  Merck joins a growing list of companies targeting lipoprotein(a), high levels of which are associated with an elevated risk of adverse cardiovascular outcomes.

  March 25, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Job Trends

  Report: 2025 U.S. Life Sciences Salary Report

  March 25, 2025

   · 

  1 min read

   · 

  BioSpace Insights
• 

  Government

  Trump Nominates Acting Director Monarez as CDC Head

  If confirmed, Susan Monarez will have her work cut out for her, facing a measles outbreak that has already killed two people—the first measles-related deaths in the U.S. since 2015.

  March 25, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug development

  Opthea, UNITY Fail to Unseat Regeneron’s Eylea in Vision Disorders

  The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s biosimilar from the U.S.

  March 25, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Layoffs

  Alector Cuts Staff Again, This Time Laying Off 13% of Workforce

  As part of cost-cutting efforts, Alector is letting go of about 25 people as it focuses on advancing its preclinical and research pipeline. Alector is also continuing clinical-stage work on programs for frontotemporal dementia and Alzheimer’s disease.

  March 25, 2025

   · 

  2 min read

   · 

  Angela Gabriel
• 

  Alzheimer’s disease

  Cassava Finally Ends Alzheimer’s Program for Embattled Simufilam

  After years of controversy and allegations of doctored data, Cassava is moving on from Alzheimer’s.

  March 25, 2025

   · 

  1 min read

   · 

  Annalee Armstrong
• 

  Compensation

  Average Life Sciences Salaries Up 9% in 2024, but Bonuses and Equity Values Drop: BioSpace Report

  The 9% average salary increase from 2023 to 2024 was the largest for life sciences professionals since 2021. Several factors could be behind the spike, including companies providing higher pay because bonuses and stock compensation went down.

  March 25, 2025

   · 

  3 min read

   · 

  Angela Gabriel
• 

  Policy

  Trump Doubles Down on Pharma Tariff Threats

  President Donald Trump’s tariffs on pharmaceuticals “to come at some point,” per CNBC, as companies promise to build infrastructure in the U.S.

  March 25, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Immunology and inflammation

  Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline

  Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.

  March 25, 2025

   · 

  2 min read

   · 

  Dan Samorodnitsky
• 

  Vaccines

  GSK Builds on Real-World Experiment to Study Shingrix’s Impact on Dementia

  The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” experiment to determine whether 65- and 66-year-olds who received GSK’s shingles vaccine Shingrix have reduced dementia risk.

  March 25, 2025

   · 

  1 min read

   · 

  Dan Samorodnitsky